Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Pilot Study of Serum Proteomic Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
No phase specified	Diagnostic	Completed	18 to 85	NCI	NCI-03-C-0228 NCT00066664

Trial Description

Purpose:

The presence of specific serum proteins may allow a doctor to determine if a patient has mycosis fungoides /cutaneous T-cell lymphoma.

This clinical trial is studying how well blood protein analysis detects mycosis fungoides/cutaneous T-cell lymphoma.

Eligibility:

Eligibility criteria include the following:

• 18-85 years old
• Healthy volunteer or participant with either psoriasis or mycosis fungoides/cutaneous T-cell lymphoma
• More than 2 weeks since systemic therapy for skin disease
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will complete questionnaires and undergo a whole-body skin examination. Blood samples will be collected and analyzed.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

NCI - Center for Cancer Research

Mark Udey, MD, PhD, Principal investigator		Ph: 301-496-2481

Registry Information
Official Title		Characterization of Serum Proteomic Patterns in Neoplastic and Inflammatory Skin Disease
Trial Start Date		2003-06-27
Trial Completion Date		2007-12-31
Registered in ClinicalTrials.gov		NCT00066664
Date Submitted to PDQ		2003-06-27
Information Last Verified		2007-12-10

Back to Top